An international company serving a variety of industries was seeking support in identifying potential checkpoint inhibitors for acquisition. Thus, Kineticos was tasked with conducting an exhaustive analysis of the oncology clinical trials pipeline to support the client’s strategic initiatives. 


Kineticos leveraged its proprietary database along with supplemental sources to identify potential checkpoint inhibitor candidates across various stages of development. Kineticos also researched key data on each product candidate and their respective sponsor as the client planned on leveraging the deliverable to identify potential partners.


Kineticos aggregated the data and provided the leadership team with a comprehensive worksheet of all relevant checkpoint inhibitor candidates. The worksheet also included supplemental data on each candidate allowing the sponsor to enhance their targeting strategy. The sponsor built the targets into their partnering strategy and planned to leverage the worksheet in prioritizing potential partner companies.